Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 6145 | 245 | 0.3089 | 0.3648 | 0.0399 | 0.0413 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 9635 | 173 | 0.4953 | 0.4364 | 0.0180 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 8079 | 212 | 0.4118 | 0.4364 | 0.0262 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 7818 | 140 | 0.4019 | 0.4364 | 0.0179 | 0.0207 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 5747 | 125 | 0.2943 | 0.3050 | 0.0218 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 6343 | 121 | 0.3257 | 0.3050 | 0.0191 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 5769 | 132 | 0.2951 | 0.3050 | 0.0229 | 0.0212 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 4016 | 78 | 0.2061 | 0.2010 | 0.0194 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 4327 | 93 | 0.2216 | 0.2010 | 0.0215 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 3430 | 84 | 0.1752 | 0.2010 | 0.0245 | 0.0218 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 3954 | 69 | 0.2034 | 0.1687 | 0.0175 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 3199 | 50 | 0.1648 | 0.1687 | 0.0156 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 2686 | 53 | 0.1378 | 0.1687 | 0.0197 | 0.0176 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 4811 | 91 | 0.2471 | 0.2452 | 0.0189 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 4759 | 106 | 0.2436 | 0.2452 | 0.0223 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 4787 | 110 | 0.2448 | 0.2452 | 0.0230 | 0.0214 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 3302 | 117 | 0.1667 | 0.1598 | 0.0354 | 0.0325 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 3269 | 84 | 0.1667 | 0.1598 | 0.0257 | 0.0325 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 2890 | 105 | 0.1458 | 0.1598 | 0.0363 | 0.0325 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 2096 | 82 | 0.1054 | 0.1035 | 0.0391 | 0.0423 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 2270 | 89 | 0.1142 | 0.1035 | 0.0392 | 0.0423 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1827 | 89 | 0.0910 | 0.1035 | 0.0487 | 0.0423 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1649 | 67 | 0.0828 | 0.0757 | 0.0406 | 0.0403 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1554 | 62 | 0.0781 | 0.0757 | 0.0399 | 0.0403 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.000 | uM | 72 | hr | 1 | 19971 | 929 | 0.9642 | 1.0000 | 0.0465 | 0.0504 |